ストックスクリーナーアプリを入手
4.465
3.14%
0.135
前日終値:
$4.33
開ける：
$4.34
24時間の取引高:
2.04M
Relative Volume:
1.00
時価総額：
$483.21M
収益：
-
当期純損益:
$-240.91M
株価収益率:
-1.9866
EPS:
-2.2476
ネットキャッシュフロー:
$-202.83M
1週間 パフォーマンス:
+19.41%
1か月 パフォーマンス:
+23.02%
6か月 パフォーマンス:
+31.73%
1年 パフォーマンス:
-53.09%
1日の値動き範囲:
$4.175
$4.485
1週間の範囲:
$3.63
$4.485
52週間の値動き範囲:
$2.19
$9.805
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
名前
Rocket Pharmaceuticals Inc
セクター
電話
646-440-9100
住所
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
4.465 | 468.60M | 0 | -240.91M | -202.83M | -2.2476 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.11 | 122.71B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.77 | 82.91B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
772.25 | 50.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.82 | 43.42B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
322.99 | 38.98B | 4.98B | 69.60M | 525.67M | 0.5198 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-08-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-30 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-05-28 | ダウングレード | Goldman | Neutral → Sell |
| 2025-05-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-05-28 | ダウングレード | Jefferies | Buy → Hold |
| 2025-05-28 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | ダウングレード | Needham | Buy → Hold |
| 2025-05-27 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2024-12-30 | 開始されました | Wedbush | Outperform |
| 2024-12-18 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-04-02 | 開始されました | Goldman | Neutral |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 開始されました | Morgan Stanley | Overweight |
| 2022-11-08 | 開始されました | Canaccord Genuity | Buy |
| 2022-11-01 | 開始されました | BTIG Research | Buy |
| 2022-07-08 | 開始されました | Raymond James | Outperform |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2021-02-18 | 開始されました | Needham | Buy |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-12-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 開始されました | JP Morgan | Overweight |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2019-11-06 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-26 | 開始されました | Piper Jaffray | Overweight |
| 2019-04-23 | 開始されました | Robert W. Baird | Outperform |
| 2019-03-15 | 開始されました | BofA/Merrill | Buy |
| 2019-02-05 | 開始されました | Oppenheimer | Outperform |
| 2018-09-13 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-10 | 開始されました | William Blair | Outperform |
すべてを表示
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - The Joplin Globe
Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by Monaco Asset Management SAM - MarketBeat
Aug Shorts: What are analysts price targets for Rocket Pharmaceuticals Inc2025 Growth vs Value & Fast Entry Momentum Alerts - baoquankhu1.vn
Is Rocket Pharmaceuticals Inc. Equity Warrant stock good for income investors2025 Trade Ideas & Safe Capital Growth Stock Tips - mfd.ru
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in rising dollar environmentTrade Exit Report & Daily Profit Maximizing Trade Tips - mfd.ru
Analysts Recommend Rocket Pharmaceuticals as a Top Buy - Intellectia AI
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Finviz
Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Martin Wilson Sells 12,253 Shares - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Insider John Militello Sells 3,726 Shares - MarketBeat
Why Rocket Pharmaceuticals Inc. stock could rally in 2025Trade Risk Assessment & Daily Risk Controlled Trade Plans - mfd.ru
Is Rocket Pharmaceuticals Inc. stock a good pick for beginnersJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - mfd.ru
Aug Outlook: What are analysts’ price targets for Rocket Pharmaceuticals Inc.July 2025 Fed Impact & High Return Trade Opportunity Guides - mfd.ru
Gains Recap: Is Rocket Pharmaceuticals Inc. Equity Warrant forming a breakout pattern2025 Stock Rankings & Momentum Based Trading Signals - mfd.ru
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat
Should I average down on Rocket Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Verified Chart Pattern Signals - mfd.ru
Market Overview: Is Rocket Pharmaceuticals Inc forming a bullish divergence2025 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
Stock Recap: Should I trade or invest in Rocket Pharmaceuticals Inc Equity WarrantJuly 2025 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
Recap Report: What are analysts price targets for Rocket Pharmaceuticals IncMarket Risk Analysis & Smart Money Movement Tracker - baoquankhu1.vn
Earnings Report: Is Rocket Pharmaceuticals Inc showing insider buyingJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
FOMO Trade: Does LOOP have a sustainable dividendWeekly Trade Summary & Short-Term High Return Strategies - baoquankhu1.vn
Patterns Watch: Is AMWL stock forming a triangle pattern2025 Valuation Update & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Is Rocket Pharmaceuticals Inc. Equity Warrant a stock for growth or value investorsEarnings Performance Report & Free Verified High Yield Trade Plans - mfd.ru
Aug Summary: Is Rocket Pharmaceuticals Inc Equity Warrant a cyclical or defensive stockPortfolio Update Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Aug Movers: Is Rocket Pharmaceuticals Inc exposed to political riskPortfolio Profit Report & Verified Technical Trade Signals - baoquankhu1.vn
Is now the right time to enter Rocket Pharmaceuticals Inc. Equity WarrantQuarterly Trade Report & Technical Confirmation Trade Alerts - mfd.ru
Undervalued Penny Stocks To Consider In January 2026 - Yahoo Finance
Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Fundamentals Check: What are analysts price targets for Rocket Pharmaceuticals IncWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn
Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Unpacking A Potential 102% Upside - DirectorsTalk Interviews
Breakout Zone: Is Rocket Pharmaceuticals Inc Equity Warrant stock good for income investorsJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Pullback Watch: What is the long term forecast for Rocket Pharmaceuticals Inc stock - baoquankhu1.vn
ETF Watch: Is BIPC stock heavily shortedJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Price Action: Is FCNCP stock suitable for long term investing2025 Fundamental Recap & Daily Chart Pattern Signals - baoquankhu1.vn
Aug Decliners: What is Rocket Pharmaceuticals Incs 5 year growth outlookWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals? - RTTNews
RCKT: 2026 will see key clinical milestones and a potential first commercial launch in gene therapy - TradingView
Will Rocket Pharmaceuticals Inc benefit from sector rotationJuly 2025 Volume & Technical Pattern Alert System - baoquankhu1.vn
Value Recap: What Wall Street predicts for Rocket Pharmaceuticals Inc stock priceMarket Performance Report & Daily Stock Trend Watchlist - Bộ Nội Vụ
Aug Summary: Why Rocket Pharmaceuticals Inc Equity Warrant stock remains undervaluedM&A Rumor & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Fundamentals Check: How buybacks impact Rocket Pharmaceuticals Inc. stock value2025 Pullback Review & Reliable Trade Execution Plans - Bộ Nội Vụ
Rocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart Failure - MSN
Earnings Beat: Can Rocket Pharmaceuticals Inc expand into new markets2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyMarket Sentiment Report & AI Powered Buy/Sell Recommendations - ulpravda.ru
Published on: 2026-01-10 12:46:55 - Улправда
Rocket Pharmaceuticals, Inc.Common Stock (NQ: RCKT - FinancialContent
Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 100% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsJuly 2025 Movers & Precise Entry and Exit Recommendations - ulpravda.ru
Cash per share of Rocket Pharmaceuticals, Inc. Warrant 2023- on Rocket Pharmctc – NASDAQ:RCKTW - TradingView — Track All Markets
Rocket Pharmaceuticals Inc (RCKT) 財務データ
収益
当期純利益
現金流量
EPS
Rocket Pharmaceuticals Inc (RCKT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shah Gaurav | CEO |
Feb 18 '26 |
Sale |
3.34 |
5,990 |
19,995 |
1,046,055 |
| Wilson Martin | General Counsel |
Feb 18 '26 |
Sale |
3.34 |
1,376 |
4,593 |
682,000 |
| Wilson Martin | General Counsel |
Feb 13 '26 |
Sale |
3.31 |
12,253 |
40,582 |
683,376 |
| Militello John | See Remarks |
Feb 13 '26 |
Sale |
3.31 |
3,726 |
12,341 |
92,176 |
| Shah Gaurav | CEO |
Feb 13 '26 |
Sale |
3.31 |
12,279 |
40,668 |
1,052,045 |
0.66%
0.99%
大文字化:
|
ボリューム (24 時間):